Form 4 for STAA STAAR SURGICAL CO
Accepted 2022-06-17 00:00:00 ET · period of report 2022-06-16 · accession 0001209191-22-038107 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-17 | 2022-06-16 | STAA | Lin Elizabeth Yeu | Dir | M - OptEx | $0.00 | +355 | 355 | New | $0 |
| D | 2022-06-17 | 2022-06-16 | STAA | Lin Elizabeth Yeu | Dir | M - OptEx | $0.00 | +5,765 | 5,765 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-16 | M | A | 355 | $0.00 | 355 | D | — | — | (F1) On June 16, 2022, STAAR Surgical Company's shareholders approved an increase, effective as of June 2021, in the annual equity grants to non-employee directors, which resulted in the award of an additional 355 shares of restricted stock. |
| 2 | Derivative | Common Stock Options | 2022-06-16 | M | A | 5,765 | $0.00 | 5,765 | D | $61.10 · 2023-06-16 to 2032-06-15 | 5,765 Common Stock | (F2) The options vest on the earlier of June 16, 2023 or the Corporation's 2023 Annual Shareholders Meeting, subject to her continued service through the vesting date. |